BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33777308)

  • 21. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
    Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
    J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades.
    Hong A; Lee CS; Jones D; Veillard AS; Zhang M; Zhang X; Smee R; Corry J; Porceddu S; Milross C; Elliott M; Clark J; Rose B
    Head Neck; 2016 May; 38(5):743-50. PubMed ID: 25521312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus genotypes in human immunodeficiency virus-positive patients with anal pathology in Madrid, Spain.
    García-Espinosa B; Moro-Rodríguez E; Álvarez-Fernández E
    Diagn Pathol; 2013 Dec; 8():204. PubMed ID: 24325764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
    Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
    J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status.
    Veyer D; Wack M; Grard O; Bonfils P; Hans S; Bélec L; Badoual C; Péré H
    Pathology; 2019 Jun; 51(4):421-425. PubMed ID: 31005250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
    Lim MY; Dahlstrom KR; Sturgis EM; Li G
    Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
    D'Souza G; McNeel TS; Fakhry C
    Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
    Bussu F; Sali M; Gallus R; Vellone VG; Zannoni GF; Autorino R; Dinapoli N; Santangelo R; Martucci R; Graziani C; Miccichè F; Almadori G; Galli J; Delogu G; Sanguinetti M; Rindi G; Valentini V; Paludetti G
    Br J Cancer; 2013 Mar; 108(5):1157-62. PubMed ID: 23403821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
    J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The New Face of Head and Neck Cancer: The HPV Epidemic.
    Lewis A; Kang R; Levine A; Maghami E
    Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].
    Szentirmay Z; Szántó I; Bálint I; Pólus K; Remenár E; Tamás L; Szentkúti G; Melegh Z; Nagy P; Kásler M
    Magy Onkol; 2002; 46(1):35-41. PubMed ID: 12050680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites.
    Dahlstrom KR; Li G; Tortolero-Luna G; Wei Q; Sturgis EM
    Head Neck; 2011 Jun; 33(6):847-55. PubMed ID: 20737488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, Clinicopathological Characteristics, and Outcome of Human Papillomavirus-Associated Oropharyngeal Cancer in Southern Chinese Patients.
    Lam EW; Chan JY; Chan AB; Ng CS; Lo ST; Lam VS; Chan MM; Ngai CM; Vlantis AC; Ma RK; Chan PK
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):165-73. PubMed ID: 26604268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients.
    Zamani M; Grønhøj C; Jensen DH; Carlander AF; Agander T; Kiss K; Olsen C; Baandrup L; Nielsen FC; Andersen E; Friborg J; von Buchwald C
    Eur J Cancer; 2020 Jul; 134():52-59. PubMed ID: 32460181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic and risk factors in patients with head and neck tumors.
    Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
    J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and genotype distribution of multiple human papillomavirus infections in cancer of the head and neck in a Mexican population.
    Ibieta-Zarco BR; Carrillo-García A; Ponce-de-León-Rosales S; Flores-Miranda MM; Mohar A; Lizano M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Sep; 114(3):350-7. PubMed ID: 22862976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.